NEW YORK and LONDON, December 7, 2015 Akari Therapeutics (NASDAQ: AKTX), an emerging growth, development-stage biopharmaceutical company, provided an update …
PRESS RELEASES
Akari Therapeutics Announces Upcoming Data Presentations at the 57th American Society of Hematology Annual Meeting
NEW YORK and LONDON, November 5, 2015 Akari Therapeutics (NASDAQ: AKTX), an emerging growth, development-stage biopharmaceutical company, announced today …
Akari Therapeutics Closes $75 Million Private Placement
NEW YORK and LONDON, September 21, 2015 AAkari Therapeutics (formerly known as Celsus Therapeutics plc) (NASDAQ: AKTX), an emerging growth, …
[Read more...] about Akari Therapeutics Closes $75 Million Private Placement
